October 2004

  

"ISPOR e-BULLETIN" provides updates of recent ISPOR activities and events. For detailed information on ISPOR activities, members are encouraged to go to www.ispor.org.

 

Please pass these updates along to your colleagues.

  eBulletin Index

 

NEW THIS MONTH

**NEW**    Value in Health Vol. 7 No. 5 September/October 2004

**NEW**    Value in Health Vol. 7 No. 6 November/December 2004

**NEW**    Value in Health Vol. 7 September 2004 Special Issue

**NEW**    ISPOR European Student Chapter

**NEW**    ISPOR Student Travel Grant Awardees

**NEW**    ISPOR Student News

**NEW**    Quality of Life & Medication Compliance Special Interest Group (SIG) Forums

**NEW**    Join an ISPOR Education Task Force

 

 

ISPOR ONGOING ACTIVITIES

 

1.       Publications

2.       Meetings and Congresses

3.       Educational Activities

4.       Student News

5.       ISPOR Special Interest Groups

6.       Committee and Task Force Activities

7.       Hot Topics

8.       Important Dates to Remember

9.       Employment in Pharmacoeconomics and Outcomes Research

10.    Membership

 


  1. PUBLICATIONS

Top

 

 

VALUE IN HEALTH

 

Value in Health: Volume 7, Issue 5, September/October 2004 is online and available this month: http://www.ispor.org/valueinhealth_index.asp.  The following is the TABLE OF CONTENTS for Value in Health: Issue 5, September/October 2004

 

Editorials 

Publication of Pharmacoeconomic Data Submitted to Reimbursement or Clinical Guidelines Agencies

Josephine Mauskopf, Michael Drummond

 

Technology, Regulations, and Value in Health

Pablo Lapuerta

 

Policy Application

Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation

Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge?

Hans-Georg Eichler, Sheldon X. Kong, William C. Gerth, Panagiotis Mavros, Bengt Jonsson

 

Decision Maker Commentary

Use of Outcomes Research in Assuring Patient Safety and Quality Care, Second Plenary Session, ISPOR 8th Annual International Meeting, Arlington, VA, USA

Mark B. McClellan

 

Empirical

Return on Investment of Different Combinations of Bupropion SR Dose and Behavioral Treatment for Smoking Cessation in a Health Care Setting: An Employer's Perspective

Harold S. Javitz, Gary E. Swan, Susan M. Zbikowski, Susan J. Curry, Timothy A. McAfee, Donna Decker, Richard Patterson, Lisa M. Jack

 

Medical Care Costs Associated with Postmenopausal Estrogen Plus Progestogen Therapy

Robert L. Ohsfeldt, Norma I. Gavin, John M. Thorp

 

Cost-Effectiveness of Interferon Beta-1a, Interferon Beta-1b, and Glatiramer Acetate in Newly Diagnosed Non-primary Progressive Multiple Sclerosis

Lisa A. Prosser, Karen M. Kuntz, Amit Bar-Or, Milton C. Weinstein

 

Outcomes and Costs of Risperidone versus Olanzapine in Patients with Chronic Schizophrenia or Schizoaffective Disorders: A Markov Model

Montserrat Vera-Llonch, Thomas E Delea, Erin Richardson, Marcia Rupnow, Amy Grogg, Gerry Oster

 

Methodology

Comparing Medications in a Therapeutic Area Using an NNT Model

J. Jaime Caro, K. Jack Ishak, Ingrid Caro, Kristen Migliaccio-Walle, Wendy S. Klittich

 

Portfolio Theory and Cost-Effectiveness Analysis: A Further Discussion

Pedram Sendi, Maiwenn J. Al, Frans F. H. Rutten

 

Comparison of the HUI3 with the SF-36 Preference Based SF-6D in a Clinical Trial Setting

Hind T. Hatoum, John E. Brazier, Kasem S. Akhras

 

Systematic Assessment of Decision Models in Parkinson's Disease

Uwe Siebert, Bernhard Bornschein, Tobias Walbert, Richard C. Dodel

 

Estimating Survival for Cost-Effectiveness Analyses: A Case Study in Atherothrombosis

J. Jaime Caro, Khajak J. Ishak, Kristen Migliaccio-Walle

 

Value in Health: Volume 7, September 2004 Special Issue is online and available this month: http://www.ispor.org/valueinhealth_index.asp.  The following is the TABLE OF CONTENTS for Value in Health: September 2004 Special Issue

 

Special Issue

The Needs-Based Approach to Quality of Life Assessment

Stephen P. McKenna, Lynda C. Doward

 

Defining Patient-Reported Outcomes

Lynda C. Doward, Stephen P. McKenna

 

Integrating Patient-Reported Outcomes

Stephen P. McKenna, Lynda C. Doward

 

Requirements for Quality of Life Instruments in Clinical Research

Lynda C. Doward, David M. Meads, Hanne Thorsen

 

Development of Needs-Based Quality of Life Instruments

Stephen P. McKenna, Lynda C. Doward, Mauro Niero, Rudolph Erdman

 

Application of Rasch Analysis in the Development and Application of Quality of Life Instruments

Alan Tennant, Stephen P. McKenna, Peter Hagell

 

Adapting Quality of Life Instruments

Angelo Swaine-Verdier, Lynda C. Doward, Peter Hagell, Hanne Thorsen, Stephen P. McKenna

 

Dermatological Applications of Needs-Based Quality of Life Instruments

David M. Meads, Stephen P. McKenna, Lynda C. Doward

 

Effectiveness of Needs-Based Quality of Life Instruments

Lynda C. Doward, Stephen P. McKenna, David M. Meads

 

Summary of Needs-Based Quality of Life Instruments

Stephen P. McKenna, Lynda C. Doward, David Meads, Donald Patrick, Alan Tennant

 

Value in Health: Volume 7, Issue 6, November/December 2004 is online and available this month at: http://www.ispor.org/valueinhealth_index.asp. The following is the TABLE OF CONTENTS for Value in Health: Volume 7, Issue 6, November/December 2004:

 

CONTRIBUTED PODIUM PRESENTATIONS

Value in Health; Volume 7, Issue 6, Page 637

CONTRIBUTED POSTER PRESENTATIONS

Value in Health; Volume 7, Issue 6, Page 658

DISCLOSURE INFORMATION

Value in Health; Volume 7, Issue 6, Page 806

ABSTRACT INDEX

Volume in Health; Volume 7, Issue 6, Page 811

AUTHOR INDEX

Volume in Health; Volume 7, Issue 6, Page 818

 

 ISPOR CONNECTIONS

 

ISPOR CONNECTIONS: Volume 10, Issue 4, July/August 2004 is available online to the public at: http://www.ispor.org/news/index_new.asp. 

 

HEALTH CARE COST, QUALITY, AND OUTCOMES: ISPOR BOOK OF TERMS

 

 

This ISPOR publication includes more than 100 detailed monographs covering over 400 terms used in health care delivery, management, and regulation, as well as health care outcomes research including clinical, economic, and quality-of-life research terms. ISPOR member discounted price is $36.00; a 40% discount!  Student/Library/Academic discounted price: $33.00 (a 45% discount). On-line ordering is now available at: http://www.ispor.org/publications/lexicon_index.asp.  Contact Stephen Priori at spriori@ispor.org for information on orders over 1000. 

 


  

  1. ISPOR MEETINGS AND CONGRESSES

Top

   

7TH ANNUAL EUROPEAN CONGRESS FINAL PROGRAM AVAILABLE ONLINE

24-26 October 2004, CCH Congress Centrum Hamburg, Hamburg, Germany

 

PROGRAM HOT TOPICS

ISPOR Forums

Hospital Costing Of Medical Device Therapy In A DRG Environment: 

European Perspectives

Speakers: Deborah Williams MS, Director, United States House of Representatives, Ways and Means Subcommittee on Health, Washington, DC, USA and Prof.Dr. Karl Peter Pfeiffer PhD, Institut für Biostatistik und Dokumentation, Innsbruck Medical University (ISPOR Medical Device & Diagnostics Forum)

 

Formulary Development and Reimbursement Systems in Central and Eastern Europe: Current Status and Future Direction 

Speakers: Pavel Vorobiev MD, PhD, President, ISPOR Russia Chapter and President, Newdiamed, Moscow, Russia; Ewa Orlewska MD, PhD,  Department of Experimental and Clinical Pharma, Medical University of Warsaw, Warsaw, Poland; Imre Boncz MD, MSc, National Health Insurance Fund Administration, Budapest, Hungary; Daiga Behmane, Director, Medicines’ Pricing and Reimbursement Agency, Riga, Latvia; Angelika Szalayova, Chief of Drug Department, Slovakian Ministry of Health, Kosice, Slovak Republic; Tomas Sechser MD, Head of Clinical Pharmacology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (ISPOR Central & Eastern European Forum)

 

ISPOR Workshops

 

W11: Pros And Cons Of Different Modeling Techniques From The End-User Perspective
Mesrobian X1, Van Genugten ML2
1MAPI values, Boston, MA, USA; 2Mapi Values, Houten, The Netherlands

 

W15: Parametric Survival Models and Decision Models: Relating Continuous Hazards to Discrete-Time Transition Probabilities
Briggs A
HERC - University of Oxford, Oxford, UK

 

ISPOR Roundtables

Commissioning and Supervising Studies for Outcomes Research: Challenges of External International Collaboration

Discussion Leader: Anne Marciniak MD, MPhil, MSc, MBA, Director, Worldwide Outcomes Research, Pfizer Ltd., Sandwich, Kent, UK

ISPOR Plenary Sessions (Second Plenary)

“Costs and Outcomes for Decision-making- Fourth Hurdle”

Speakers: Martin Buxton BA Soc Sci, Professor, Brunel University Health Economics Research Group, Middlesex, UK; Bernhard Gibis MD, MPH,  Kassenärztliche Bundesvereinigung, National Association of Statutory Health Insurance Physicians, Berlin, Germany; Kees de Joncheere, Regional Adviser, Health Technology and Pharmaceuticals, WHO Regional Office, Copenhagen, Denmark

 

ISPOR Issues Panels

FDA Draft Guidance for the Industry on the Assessment of  Patient-Reported Outcomes– What are the Implications for Global Clinical Research?
Moderator: Patrick Marquis MBA, MD, Managing Director,  Mapi Values, Boston, MA, USA

Panelists: David W. Miller PhD, Vice President, Global Health Outcomes, GlaxoSmithKline, Research Triangle Park, NC, USA; Ingela Wiklund PhD, Professor, Senior Principal Scientist, Global Director Outcomes Research, Astra Zeneca, Molndal, Sweden

 

Do Decision-Makers Have Less Credibility With Modeling Results?

Moderator: Uwe Siebert MD, MPH, Msc, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA and Institute For Medical Informatics, Biostatistics, and Epidemiology, University Of Munich, Munich, Germany

Panelists: Bernhard Gibis MD, MPH, Head of Department of Quality Assurance, National Association of Statutory Health Insurance Physicians (NASHIP), Berlin, Germany; Michael Drummond PhD, Director, Centre for Health Economics, University of York, York, UK

 

PROGRAM KEY FEATURES:

·         Contributed Poster presentations Session I:

http://www.ispor.org/congresses/germany1004/posters1.asp

·         Contributed Poster presentations Session II:

http://www.ispor.org/congresses/germany1004/posters2.asp

·         64 Contributed Podium Presentations

·         7 Contributed and 1 Invited Issues Panels

·         24 Contributed Workshops      

·         Medical Device & Diagnostics - Central & Eastern European Forums

 

Complete Congress Final Program available online at: http://www.ispor.org/congresses/germany1004/index.asp.

 Sign up for Exhibit Space, contract available online at

Sponsorship Opportunities still available, for more information go to:

 

 

ISPOR 7th ANNUAL EUROPEAN CONGRESS PERSONAL PROGRAM SCHEDULER NOW AVAILABLE

 

To benefit Congress attendees ISPOR has a new feature for the ISPOR 7th Annual European Congress in Hamburg, Germany, the Personal Scheduler.  Now you are in control of what events and sessions you would like to attend with this unique planning tool.

 

With just the lick of your mouse, the ISPOR Personal Scheduler will allow you to maximize your time at the congress by:

• searching or browsing events scheduled for this meeting

• creating your own individual schedule of events

• checking for conflicts

• recording notes

• downloading to your Personal Digital Assistant (PDA).

 

The ISPOR Personal Program Scheduler is available at:

 

The Personal Program Scheduler is a free service provided to those registered to attend the ISPOR 7th Annual European Congress from 24-26 October in Hamburg, Germany at the CCH Congress Centrum Hamburg.

 

10TH ANNUAL INTERNATIONAL MEETING

May 15-18, 2005, Marriott Wardman Park Hotel, Washington, DC, USA

 

             **NEW** ISPOR 10th ANNUAL INTERNATIONAL MEETING CALL FOR ABSTRACTS

            http://www.ispor.org/meetings/washington0505/index.asp

            Abstract Submission begins: October 1, 2004 – Abstract Submission Deadline: January 10, 2005

 

 


 

  1. EDUCATION ACTIVITIES

Top

             ISPOR 7th Annual European Congress Short Courses

 

Short Courses: Saturday, 23 October 2004:

·          The Analysis and Interpretation of Quality of Life and Patient Reported Outcomes 

·         Pharmacoeconomics for the Health Care Decision-Makers

·         Elements of Pharmaceutical Pricing

·         Utility Measurements (Preference-based Techniques)

·         Cost Estimation and Assessing Financial (Budget) Impact of New HealthCare Technologies

 

For Short Courses descriptions, go to: http://www.ispor.org/congresses/germany1004/sc231004.asp

            

 

Short Courses: Sunday, 24 October 2004:

·          European Databases and Retrospective Database Analysis

·         International Studies in Patient-Reported Outcomes

·         Health Care and Reimbursement Systems in Europe

·         Pharmacoeconomic Modeling

·         Bayesian Methods in Economic Evaluations

 

For Short Course descriptions, go to: http://www.ispor.org/congresses/germany1004/sc241004.asp

 

           

ISPOR Distance Learning Program on the ISPOR website:

             ISPOR Distance Learning Program

 

The following modules are available:

 

  Pharmacoeconomics

  • The Role of Pharmacoeconomics (FREE)

 

Pharmacoeconomic Evaluations &  Methods

  • Cost Analysis in Pharmacoeconomics (I) – The Classification of Costs
  • Cost Analysis in Pharmacoeconomics (II) – The Health Care Production Function
  • An Introduction to Decision Theory
  • Markov Modeling in Decision Analysis
  • Evaluating a Pharmacoeconomic Study
  • Discounting Costs and Benefits
  • Modeling in Pharmacoeconomics

 

Cost-Effectiveness Analysis

  • Cost-Effectiveness Modeling in Pharmacoeconomics  
  • Interpreting Cost-Effectiveness Claims

 

Cost-Benefit Analysis

  • Theoretical Foundations of Cost Benefit Analysis
  • Measuring Willingness-to-Pay

 

Cost-Utility Analysis

  • Theoretical Foundations of Cost-Utility Analysis
  • Measuring Values and Utilities
  • Quality Adjusted Life Years (QALYs)

 

Humanistic Outcomes (Utilities, Health-related Quality of Life, Patient-reported Outcomes, Patient Preferences)

  • A Typology of Outcomes Instruments
  • The SF-36 Instrument
  • The Health Utilities Index

 

Study Design in Pharmacoeconomics

  • Study Design in Pharmacoeconomic Analysis
  • Experimental Designs
  • Non-Experimental Designs

 

Guidelines and Reference Standards

  • Guidelines and Reference Standards in Pharmacoeconomics
  • The Australian Guidelines for Formulary Submissions
  • Managed Care Formulary Submission Guidelines in the United States 
  • Responding to Managed Care Guidelines in the United States
  • Guidelines Case Study: Blue Cross and Blue Shield of Colorado and Nevada

 


 

  1. STUDENT NEWS

Top

 

**NEW** ISPOR EUROPEAN STUDENT CHAPTER

We welcome the ISPOR European Student Chapter. The Student Network Forum and launch of the European Student Chapter, will be held during the ISPOR 7th European Congress on Monday October 25th at 20:00, Hamburg, Germany. 

**NEW** ISPOR STUDENT TRAVEL GRANT AWARDEES

Congratulations to the ISPOR Student Travel Grant awardees: Lam Lop Chi from the Chinese University of Hong Kong, and Witsanuchai Srijariya from Mahidol University, Bangkok Thailand.

 

Thank you to HealthCore and F. Hoffman La-Roche for making the ISPOR Student Travel Grants possible. 

**NEW** ISPOR STUDENT NEWS

The August 2004 edition of the ISPOR Student Network News, including an interview with ISPOR President Lieven Annemans, is now available at the following link: http://www.ispor.org/student/newsletter_index.asp

For more details on the ISPOR Student Network, please visit: http://www.ispor.org/student/student_index.asp

          


 

 

  1. ISPOR SPECIAL INTEREST GROUPS (SIG)

Top

 

MEDICATION COMPLIANCE SIG

**NEW** Forum
The Medication Compliance SIG organized a MED COMP Forum: Issues in Medication Compliance and Persistence Research at the 7th European Congress on Monday October 25th at 6:00PM (18:00).  For more details on the forum, including panelists: http://www.ispor.org/congresses/germany1004/102504.asp

             For more details on the SIG, please visit: http://www.ispor.org/sigs/medication.asp

 

QUALITY OF LIFE SIG

**NEW** Forum
The Quality of Life SIG organized a QOL forum: Industry & Regulatory Perspectives on Translating PRO Measures at the 7th European Congress on Monday, October 25th at 8:00 AM.  For details on the forum, including panelists:    http://www.ispor.org/congresses/germany1004/102504.asp

             For more details on the SIG, please visit: http://www.ispor.org/sigs/qol.asp

 

HEALTH TECHNOLOGY ASSESSMENT SIG

 

For more details on the SIG, please visit http://www.ispor.org/sigs/hta.asp

 

RISK MANAGEMENT SIG

 

For more details on the SIG, please visit: http://www.ispor.org/sigs/rm.asp

  
PATIENT REGISTRY SIG

 

               For more details, please visit: http://www.ispor.org/sigs/patient_registr.asp

 
MANAGED
CARE_PBM SIG

 

For more details, please visit http://www.ispor.org/sigs/sigsindex.asp

 

CLINICAL PRACTICE SIG

 

For more details, please visit: http://www.ispor.org/sigs/sigsindex.asp

 

Special Interest Group membership is open to ALL ISPOR members.

To JOIN any SIG: http://www.ispor.org/sigs/joinsig.htm

 


 

 

  1. ISPOR COMMITTEE AND TASK FORCE ACTIVITIES

Top

 

**NEW**Join an ISPOR Education Task Force:

 

ISPOR Education Task Forces:

 

1.) ISPOR Educators’ Tool Kit Task Force (**NEW TASK FORCE**)

GOAL: Develop a pharmacoeconomic “tool kit” with presentation materials and exercises that can be used by educators around the world. 

2.) ISPOR Short Course Task Force

GOAL: Oversight and development of ISPOR Short Courses including quality assurance. 

 

3.) ISPOR Distance Learning Task Force

GOAL: Oversight and development of ISPOR Distance Learning Program including quality assurance. 

 

4.)  ISPOR Learning Outcomes Task Force

GOAL: Develop pharmacoeconomics and outcomes research learning outcomes, case studies, and disseminate to researchers and users. 

 

Participation in the task forces may include small meeting participation at the ISPOR Annual Meetings and Congresses and several teleconference calls.  Most communication among members is by e-mail.

 

**IF INTERESTED, REPLY VIA E-MAIL TO edtaskforce@ispor.org BY OCTOBER 20, 2004.


  1. HOT TOPICS

Top

 

CMS ANNOUNCES DEMONSTRATION PROJECT FOR BENEFICIARIES WITH HIGH MEDICAL COSTS

 

BALTIMORE, MD – (October 1, 2004) – The Centers for Medicare & Medicare Services (CMS) today announced a demonstration to find ways to improve the health and quality of life of Medicare beneficiaries with high medical expenses while reducing costs for the program and the beneficiaries.

 

For full text of the article, go to: http://www.cms.hhs.gov/media/press/release.asp?Counter=1221

 


 

  1. IMPORTANT DATES TO REMEMBER

Top

 

            October 1, 2004 – Abstract Submission begins for the ISPOR 10th Annual International Meeting.

 

October 24-26, 2004 – ISPOR 7th Annual European Congress, CCH Congress Centrum Hamburg, Hamburg, Germany.

 


  1. EMPLOYMENT

Top

NEW POSITIONS AT THE ISPOR WEBSITE Careers

 

            Advertise your positions on ISPOR Website (1 million hits per month)

 

Participate in the PRAP (Professional Recruitment Center) at the 7th Annual European Congress! For more info, go to: Careers

 


  1. ISPOR MEMBERSHIP

Top

Update your email address at https://www.ispor.org/members/MemberProfile.aspx! Your email address is required as part of your log in information in the members only section of the ISPOR website.

 

 


eBulletin Index